3rd Quarter - Report

ARENTFOX SCHIFF LLP for AMERICAN PHARMACY COOPERATIVE, INC.

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Policies regarding transparency in prescription drug pricing and patient access to care in Medicare, Medicaid, and other insurance Pharmacy Benefit Manager (PBM) reform generally H.R. 9096 (Pharmacists Fight Back Act), regarding Pharmacy Benefit Manager (PBM) reform, all provisions

LobbyistCovered position, as disclosed
CISSY JACKSON —
DANIEL SJOSTEDT —
OLIVER SPURGEON III —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 9096 (118th)

Pharmacy PHA

Prescription drug pricing generally Pharmacy Benefit Manager (PBM) reform generally S. 2973 (Modernizing and Ensuring PBM Accountability Act), all provisions S. 1339 (Pharmacy Benefit Manager Reform Act), regarding Pharmacy Benefit Manager (PBM) reform S. 3430 (Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023), regarding Pharmacy Benefit Manager (PBM) reform H.R. 5378 (Lower Costs, More Transparency Act), regarding Pharmacy Benefit Manager (PBM) reform H.R. 6283 (DRUG Act), regarding Pharmacy Benefit Manager (PBM) reform H.R. 9096 (Pharmacists Fight Back Act), regarding Pharmacy Benefit Manager (PBM) reform, all provisions

LobbyistCovered position, as disclosed
CISSY JACKSON —
DANIEL SJOSTEDT —
OLIVER SPURGEON III —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 3430 (118th), S. 1339 (118th), H.R. 5378 (118th), H.R. 9096 (118th), S. 2973 (118th), H.R. 6283 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.